Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Large Increase in Short Interest

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the recipient of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling 18,241 shares, an increase of 34.8% from the January 29th total of 13,527 shares. Currently, 2.0% of the company’s shares are sold short. Based on an average daily volume of 24,613 shares, the days-to-cover ratio is presently 0.7 days. Based on an average daily volume of 24,613 shares, the days-to-cover ratio is presently 0.7 days. Currently, 2.0% of the company’s shares are sold short.

Virtus LifeSci Biotech Clinical Trials ETF Trading Down 0.3%

NYSEARCA BBC traded down $0.11 on Monday, hitting $42.36. The company’s stock had a trading volume of 17,112 shares, compared to its average volume of 24,786. The company’s 50-day simple moving average is $40.57 and its 200 day simple moving average is $33.67. Virtus LifeSci Biotech Clinical Trials ETF has a 52-week low of $13.42 and a 52-week high of $44.10.

Virtus LifeSci Biotech Clinical Trials ETF Company Profile

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.